Berliner Tageszeitung - AM Technical Solutions Acquires Sequence, Inc., Expanding Life Sciences Engineering and Commissioning, Qualification, and Validation (CQV) Capabilities

Sequence, headquartered in Morrisville, North Carolina, brings deep expertise in CQV, Computer System Validation (CSV), IT/OT integration, operational readiness, and life sciences engineering excellence. Their cross-functional approach to process engineering and facility startup has earned them a strong track record accelerating time to market for pharmaceutical and biopharmaceutical clients across the full project lifecycle -- from conceptual design through licensure and commercial operations.

This acquisition deepens AM's existing Engineering and CQV capabilities with proven teams delivering high-value solutions to the life sciences sector. Sequence's methodology, people, and client relationships represent a natural and intentional extension of AM's mission to deliver right-first-time outcomes for clients in the world's most demanding high-technology environments.

"Sequence has built something exceptional -- a proven team with genuine technical depth and a culture grounded in care for their people and their clients," says Dave Watrous, CEO of AM Technical Solutions. "Their understanding of the overall manufacturing lifecycle, coupled with in-depth and hands-on knowledge about each of the process steps that bring innovative therapies to life, directly strengthens our ability to serve life sciences clients at every stage of a project. This is the right partnership at the right time."

Sequence's values-driven culture and commitment to developing its people and community align closely with AM's own principles of integrity, innovation, and care. The Sequence team will continue operating under its established leadership, with the full backing of AM's global platform, resources, and project delivery network.

"Joining AM Technical Solutions gives our team access to a global network of engineering and construction expertise that will meaningfully expand what we can offer our clients," says Mike Putnam, Founder and CEO of Sequence, Inc. "Our focus on quality, compliance, and client outcomes remains unchanged. AM's platform strengthens and accelerates what we've already built."

This combination brings a unique solution to the market, backed by both technical strength and execution scale, that improves project delivery results and reduces the coordination burden on clients, creating a single point of accountability from project conceptualization to go-live product manufacturing.

- Learn more about AM Technical Solutions at AMTS.com.

- Learn more about Sequence at SequenceQCS.com.

ABOUT AM TECHNICAL SOLUTIONS: Founded in 1994, AM is a global architecture, engineering, construction, and commissioning firm for high-tech markets. AM targets semiconductor, life science, data center, solar, aerospace, research, university, and other high-technology facilities. AM has successfully managed over $30 billion in capital projects, cleanroom construction builds, and facility expansions for more than 170 different customers in 26 different countries. AM's Global Headquarters are in Austin, Texas, with multiple regional offices across North America, Asia, and Europe.

ABOUT SEQUENCE, INC.: Sequence is an engineering consulting firm specializing in ensuring that facilities and manufacturing processes are designed and tested to meet end-user requirements for regulated industries. Through a fully functional, mock pharmaceutical manufacturing training facility, consultants are trained in a hands-on environment that is unique in the industry that includes both equipment and software. Founded in 2002, Sequence provides consulting solutions to clients across North America and parts of Europe. The company is headquartered in the heart of RTP at 1400 Perimeter Park Drive in Morrisville, NC with a second hub in Framingham, MA.

Contact Information

Tim Glasson
President, Life Sciences
[email protected]
214-287-0432

SOURCE: AM Technical Solutions, Inc.

View the original press release on ACCESS Newswire

N. Nilsson--BTZ